✦ LIBER ✦

Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study

✍ Scribed by Johanna U. Mäenpää; Seija E. Grénman; Jyrki T. Jalkanen; Tapio A. Kuoppala; Arto O. Leminen; Ulla S. Puistola; Päivi M. Vuolo-Merilä; Merja H. Yliskoski

Book ID: 113960295
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 115 KB
Volume: 101
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.09.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase II feasibility study of carbopla

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

First-line gemcitabine and carboplatin i

First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study

✍ SK Tay; A Ilanchadran; TY Tan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Phase II study of sequential doublets: t

Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer

✍ Alan N Gordon; Lina Asmar; Mark J Messing; Daron G Street; Charles H Pippitt Jr. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 186 KB

A randomized phase II study of paclitaxe

A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma

✍ F.Y.F.L De Vos; A.M.E. Bos; M. Schaapveld; C.A.M. de Swart; H. de Graaf; A.G.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB